search
Back to results

Persona Ti-Nidium Post-Market Clinical Follow-up (TKA)

Primary Purpose

Knee Pain Chronic, Osteoarthritis, Rheumatoid Arthritis

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Zimmer Biomet Persona Ti-Nidium Total Knee System
Sponsored by
Zimmer Biomet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Knee Pain Chronic focused on measuring Osteoarthritis, Rheumatoid Arthritis, Total Knee Arthroplasty

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patient is of legal age and skeletally mature
  2. Patient is willing and able to provide written Informed Consent by signing and dating the IRB-approved Informed Consent document
  3. Patient is willing and able to complete scheduled follow-up evaluations as defined in the study protocol
  4. Patient qualifies for total knee arthroplasty based upon physical exam and medical history, and meets the approved indications for use of the Persona Ti-Nidium Knee System and Vivacit-E polyethylene articulating surface
  5. Independent of study participation, patient is a candidate for the commercially available Persona Ti-Nidium Knee and Vivacit-E polyethylene articulating surface, implanted in accordance with product labeling

Study Device Inclusion Criteria:

The Persona Ti-Nidium Total Knee is intended for patients with severe pain and disability due to the following:

  1. Rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis.
  2. Collagen disorders, and/or avascular necrosis of the femoral condyle.
  3. Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy.
  4. Moderate valgus, varus, or flexion deformities.

Exclusion Criteria:

  1. Patient is unwilling to sign the Informed Consent
  2. Patient is currently participating in any other surgical intervention or pain management study
  3. Patient is pregnant or considered a member of a protected (vulnerable) population whose inclusion in the study is inappropriate (e.g. prisoner, mentally incompetent)
  4. Patient has a mental or neurologic condition who is unwilling or incapable of following postoperative care instructions
  5. Patient has a condition which would, in the judgement of the Investigator, place the patient at undue risk or interfere with the conduct of the study
  6. Patient is institutionalized or is a known drug abuser, a known alcoholic or cannot understand the requirements of study participation

Study Device Exclusion Criteria

  1. Previous history of infection in the affected joint and/or other local/systematic infection that may affect the prosthetic joint
  2. Insufficient bone stock on femoral or tibial surfaces
  3. Skeletal immaturity
  4. Neuropathic arthropathy
  5. Osteoporosis or any loss of musculature or neuromuscular disease that compromises the affected limb
  6. A stable, painless arthrodesis in a satisfactory functional position
  7. Severe instability secondary to the absence of collateral ligament integrity
  8. Rheumatoid arthritis (RA) accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin
  9. The kinematic alignment surgical technique is contraindicated for patients with greater than 5° valgus deformity with medial collateral ligament (MCL) insufficiency

Sites / Locations

  • Denver Hip & Knee, Inc.Recruiting
  • MedStar Health Research InstituteRecruiting
  • Mississippi Sports Medicine and Orthopaedic Center
  • New Mexico Orthopaedic Associates
  • Duke University
  • Monument Health Rapid City Hospital, Inc.

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Persona Ti-Nidium

Arm Description

Primary total knee arthroplasty subjects that receive the Zimmer Biomet Persona Ti-Nidium Total Knee System

Outcomes

Primary Outcome Measures

Oxford Knee Score (OKS)
A patient reported functional outcome score for knee arthroplasty. This score ranges from 0-48, with higher scores indicating a better outcome.

Secondary Outcome Measures

Knee Society Score (KSS) Expectations (pre and post op)
This is a 3 question form regarding a patient's expectations of the total knee replacement. The pre-op form assesses the patient's expectations of the knee replacement, and the post-op form addresses how the replacement is meeting said expectations. The score ranges from 3-15, with higher scores indicating a better outcome.
EuroQol Five Dimension Five Level (EQ-5D-5L) Outcomes Measure
A questionnaire completed by the patient and assesses his/her general health status. This score ranges from -0.573 to 1, with higher recorded scores indicating better overall health.

Full Information

First Posted
March 23, 2021
Last Updated
October 18, 2022
Sponsor
Zimmer Biomet
search

1. Study Identification

Unique Protocol Identification Number
NCT04817969
Brief Title
Persona Ti-Nidium Post-Market Clinical Follow-up
Acronym
TKA
Official Title
Persona® Ti-Nidium® Personalized Total Knee System A Post-Market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data Using the Persona Ti-Nidium Total Knee System and Instrumentation
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2021 (Actual)
Primary Completion Date
May 2034 (Anticipated)
Study Completion Date
May 2034 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Zimmer Biomet

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The main objectives of this study are to evaluate overall clinical performance and safety of the Persona Ti-Nidium implant in total knee arthroplasty.
Detailed Description
The study design is a prospective, multicenter data collection model of the 510(k) cleared Persona Ti-Nidium Total Knee System. The study will require each site to obtain institutional review board (IRB) approval prior to study enrollment. All potential study subjects will be required to participate in the Informed Consent Process. All study subjects will undergo preoperative clinical evaluations prior to their total knee arthroplasty. Investigators will collect clinical data for a required 10 years. Follow-up clinical visits include Early Post-op, 6 months, 1 year, 2, 3, 5, 7 and 10 years post-operatively. The objective of this study is to evaluate clinical performance, benefits and safety of the Persona Ti-Nidium implant in total knee arthroplasty. Specific assessments include: Confirming the long-term safety, performance and clinical benefits of the Persona Ti-Nidium total knee system and instrumentation in primary and revision TKA. Verifying that, under normal use, the performance and clinical benefits of this device and its instrumentation conform to those intended by the manufacturer by recording patient-reported clinical outcomes measures (PROMs) and radiographic outcomes (if available).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Pain Chronic, Osteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis, Polyarthritis, Varus Deformity, Valgus Deformity, Flexion Deformity of the Knee, Avascular Necrosis, Patellofemoral Osteoarthritis
Keywords
Osteoarthritis, Rheumatoid Arthritis, Total Knee Arthroplasty

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
240 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Persona Ti-Nidium
Arm Type
Other
Arm Description
Primary total knee arthroplasty subjects that receive the Zimmer Biomet Persona Ti-Nidium Total Knee System
Intervention Type
Device
Intervention Name(s)
Zimmer Biomet Persona Ti-Nidium Total Knee System
Intervention Description
Primary Knee Total Arthroplasty
Primary Outcome Measure Information:
Title
Oxford Knee Score (OKS)
Description
A patient reported functional outcome score for knee arthroplasty. This score ranges from 0-48, with higher scores indicating a better outcome.
Time Frame
10 years
Secondary Outcome Measure Information:
Title
Knee Society Score (KSS) Expectations (pre and post op)
Description
This is a 3 question form regarding a patient's expectations of the total knee replacement. The pre-op form assesses the patient's expectations of the knee replacement, and the post-op form addresses how the replacement is meeting said expectations. The score ranges from 3-15, with higher scores indicating a better outcome.
Time Frame
10 years
Title
EuroQol Five Dimension Five Level (EQ-5D-5L) Outcomes Measure
Description
A questionnaire completed by the patient and assesses his/her general health status. This score ranges from -0.573 to 1, with higher recorded scores indicating better overall health.
Time Frame
10 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient is of legal age and skeletally mature Patient is willing and able to provide written Informed Consent by signing and dating the IRB-approved Informed Consent document Patient is willing and able to complete scheduled follow-up evaluations as defined in the study protocol Patient qualifies for total knee arthroplasty based upon physical exam and medical history, and meets the approved indications for use of the Persona Ti-Nidium Knee System and Vivacit-E polyethylene articulating surface Independent of study participation, patient is a candidate for the commercially available Persona Ti-Nidium Knee and Vivacit-E polyethylene articulating surface, implanted in accordance with product labeling Study Device Inclusion Criteria: The Persona Ti-Nidium Total Knee is intended for patients with severe pain and disability due to the following: Rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis. Collagen disorders, and/or avascular necrosis of the femoral condyle. Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy. Moderate valgus, varus, or flexion deformities. Exclusion Criteria: Patient is unwilling to sign the Informed Consent Patient is currently participating in any other surgical intervention or pain management study Patient is pregnant or considered a member of a protected (vulnerable) population whose inclusion in the study is inappropriate (e.g. prisoner, mentally incompetent) Patient has a mental or neurologic condition who is unwilling or incapable of following postoperative care instructions Patient has a condition which would, in the judgement of the Investigator, place the patient at undue risk or interfere with the conduct of the study Patient is institutionalized or is a known drug abuser, a known alcoholic or cannot understand the requirements of study participation Study Device Exclusion Criteria Previous history of infection in the affected joint and/or other local/systematic infection that may affect the prosthetic joint Insufficient bone stock on femoral or tibial surfaces Skeletal immaturity Neuropathic arthropathy Osteoporosis or any loss of musculature or neuromuscular disease that compromises the affected limb A stable, painless arthrodesis in a satisfactory functional position Severe instability secondary to the absence of collateral ligament integrity Rheumatoid arthritis (RA) accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin The kinematic alignment surgical technique is contraindicated for patients with greater than 5° valgus deformity with medial collateral ligament (MCL) insufficiency
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tim Swanson
Phone
5745497606
Email
tim.swanson@zimmerbiomet.com
First Name & Middle Initial & Last Name or Official Title & Degree
Charles Jaggard
Phone
3172603841
Email
Charles.Jaggard@zimmerbiomet.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hillary Overholser
Organizational Affiliation
Zimmer Biomet Assoc Director
Official's Role
Study Director
Facility Information:
Facility Name
Denver Hip & Knee, Inc.
City
Parker
State/Province
Colorado
ZIP/Postal Code
80134
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amy Gridley
Phone
303-925-4750
Email
acrafferty@msn.com
First Name & Middle Initial & Last Name & Degree
Derek Johnson, MD
Facility Name
MedStar Health Research Institute
City
Hyattsville
State/Province
Maryland
ZIP/Postal Code
20782
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Henry Artigues
Phone
301-560-7300
Email
Henry.Artigues@Medstar.net
First Name & Middle Initial & Last Name & Degree
Henry Boucher, MD
First Name & Middle Initial & Last Name & Degree
Robert McKinstry, MD
First Name & Middle Initial & Last Name & Degree
Thomas Ring, MD
Facility Name
Mississippi Sports Medicine and Orthopaedic Center
City
Jackson
State/Province
Mississippi
ZIP/Postal Code
39202
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
New Mexico Orthopaedic Associates
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87110
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Duke University
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27708
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ashley Browning Young
Phone
919-681-9755
Email
Ashley.b.Young@duke.edu
First Name & Middle Initial & Last Name & Degree
Samuel Wellman, MD
First Name & Middle Initial & Last Name & Degree
Michael Bolognesi, MD
First Name & Middle Initial & Last Name & Degree
Thorsten Seyler, MD
Facility Name
Monument Health Rapid City Hospital, Inc.
City
Rapid City
State/Province
South Dakota
ZIP/Postal Code
57701
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Crystal Gruetzmacher
Phone
605-755-3763
Email
CGruetzmac@monument.health
First Name & Middle Initial & Last Name & Degree
Kipp Gould, DO

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Persona Ti-Nidium Post-Market Clinical Follow-up

We'll reach out to this number within 24 hrs